Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Alireza Labani‐Motlagh"'
Autor:
Fan Yang, Alireza Labani-Motlagh, Jose Alejandro Bohorquez, Josimar Dornelas Moreira, Danish Ansari, Sahil Patel, Fabrizio Spagnolo, Jon Florence, Abhinav Vankayalapati, Tsuyoshi Sakai, Osamu Sato, Mitsuo Ikebe, Ramakrishna Vankayalapati, John J. Dennehy, Buka Samten, Guohua Yi
Publikováno v:
Communications Biology, Vol 7, Iss 1, Pp 1-13 (2024)
Abstract The continuing emergence of new strains of antibiotic-resistant bacteria has renewed interest in phage therapy; however, there has been limited progress in applying phage therapy to multi-drug resistant Mycobacterium tuberculosis (Mtb) infec
Externí odkaz:
https://doaj.org/article/1ac890637fe24a00b09370f2537cb206
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss , Pp 508-518 (2021)
Immunostimulatory gene therapy utilizing oncolytic viruses (OVs) as gene vehicles is a promising immunotherapy for cancer. Since viruses are immunogenic, systemic delivery can be troublesome due to neutralizing antibodies. Nevertheless, local deliver
Externí odkaz:
https://doaj.org/article/a9ea76289a6b4328868b148171a9c17b
Autor:
Alireza Ahmadi, Zahra Fallah Vastani, Mahdi Abounoori, Mahdieh Azizi, Alireza Labani‐Motlagh, Sajad Mami, Sanaz Mami
Publikováno v:
Health Science Reports, Vol 5, Iss 1, Pp n/a-n/a (2022)
Abstract Background Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS) that T cells become autoreactive by recognizing CNS antigens. Both innate and adaptive immune systems are involved in the pathogenes
Externí odkaz:
https://doaj.org/article/6a6288d89b2b4d648e7804775609d89c
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
The success of cancer immunotherapy relies on the knowledge of the tumor microenvironment and the immune evasion mechanisms in which the tumor, stroma, and infiltrating immune cells function in a complex network. The potential barriers that profoundl
Externí odkaz:
https://doaj.org/article/7f32c86fb6314504b51ec39e0717939a
Autor:
Fan Yang, Alireza Labani-Motlagh, Josimar Dornelas Moreira, Danish Ansari, Jose Alejandro Bohorquez, Sahil Patel, Fabrizio Spagnolo, Jon Florence, Abhinav Vankayalapati, Ramakrishna Vankayalapati, John J. Dennehy, Buka Samten, Guohua Yi
Publikováno v:
bioRxiv
The continuing emergence of new strains of antibiotic-resistant bacteria has renewed interest in phage therapy; however, there has been limited progress in applying phage therapy to multi-drug resistantMycobacterium tuberculosis(Mtb) infections. In t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f45a1d2748d919ace97db1744cccc0ae
https://doi.org/10.2139/ssrn.4382958
https://doi.org/10.2139/ssrn.4382958
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss, Pp 508-518 (2021)
Molecular Therapy Oncolytics
Molecular Therapy Oncolytics
Immunostimulatory gene therapy utilizing oncolytic viruses (OVs) as gene vehicles is a promising immunotherapy for cancer. Since viruses are immunogenic, systemic delivery can be troublesome due to neutralizing antibodies. Nevertheless, local deliver
Autor:
Alireza Ahmadi, Zahra Fallah Vastani, Mahdi Abounoori, Mahdieh Azizi, Alireza Labani‐Motlagh, Sajad Mami, Sanaz Mami
Publikováno v:
Health Science Reports, Vol 5, Iss 1, Pp n/a-n/a (2022)
Background Multiple sclerosis (MS) is an autoimmune inflammatory disease of the central nervous system (CNS) that T cells become autoreactive by recognizing CNS antigens. Both innate and adaptive immune systems are involved in the pathogenesis of MS.
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Frontiers in Immunology
Frontiers in Immunology
The success of cancer immunotherapy relies on the knowledge of the tumor microenvironment and the immune evasion mechanisms in which the tumor, stroma, and infiltrating immune cells function in a complex network. The potential barriers that profoundl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::65c5386f4b0a0657df4997c79c1a9dcc
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-414504
http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-414504
Publikováno v:
Cancer Research. 81:1689-1689
Immunostimulatory gene therapy using oncolytic viruses - OV - for combined gene transfer and tumor-specific oncolysis is a promising immunotherapy for cancer. Due to neutralizing antibodies in the blood, OVs are commonly administered by intratumoral
Autor:
Ivan Nagaev, Eva Lundin, Pernilla Israelsson, Eva Dehlin, Alireza Labani-Motlagh, Ulrika Ottander, Lucia Mincheva-Nilsson, Olga Nagaeva
Objective: Tumor establishment, metastatic spreading and poor survival in ovarian cancer is strongly associated with progressive derangement of the patient’s immune system. Accumulating evidence suggests that immune impairment is influenced by the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9520037dca378388206ce43f31cf971b
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-138256
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-138256